Medication info
CANTACAN Tablets 16 mg (Candesartan Cilexetil)

CANTACAN Tablets 16 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Celtrion Pharmaceutical Co., Ltd.
Appearance
Pink, round, biconvex tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201506686 · Approved 2015.09.22 · Insurance code 693901860

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. Elderly patients: No adjustment of the initial dose is necessary. Patients with intravascular volume depletion (Intravascular volume depletion): For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension Adolescents and children 18 years of age or younger: Safety and efficacy have not been established. 2. Heart failure Adolescents and children 18 years of age or younger: Safety and efficacy have not been established.

Ingredients

Manufacturer
Celtrion Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • left ventricular systolic dysfunction
  • reduced left ventricular ejection fraction
View approved original text

This medication effectively lowers blood pressure in patients with hypertension, helping to reduce cardiovascular risk. It is also suitable for patients with heart failure who have reduced left ventricular systolic function, complementing ACE inhibitor treatment or for those intolerant to such treatments. It particularly benefits patients with heart failure classified as NYHA Class II to IV, with a left ventricular ejection fraction of 40% or less, improving cardiac function and alleviating symptoms. Therefore, this medication is effectively used for symptom improvement and cardiac function enhancement in patients with hypertension and certain heart failures.

How to take

Adult dose

This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. Elderly patients: No adjustment of the initial dose is necessary. Patients with intravascular volume depletion (Intravascular volume depletion): For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension Adolescents and children 18 years of age or younger: Safety and efficacy have not been established. 2. Heart failure Adolescents and children 18 years of age or younger: Safety and efficacy have not been established.

Precautions

This medication can cause severe harm to a fetus and newborn if taken during pregnancy; if pregnancy is confirmed, it should be stopped immediately. Patients with allergies to this medication, women who are pregnant or breastfeeding, individuals with severe liver disease, or those with certain genetic conditions should not take this medication. Elderly patients, those with renal impairment, patients with liver disease, or those with heart valve diseases should use this medication cautiously, with regular monitoring of blood pressure and renal function. Side effects may include dizziness, back pain, respiratory infections and more. For heart failure patients, hypotension, hyperkalemia, and renal function decline may occur more frequently. It is important to regularly check potassium levels and renal function indicators through blood tests, especially when taking with other antihypertensive medications or potassium supplements. This medication may enhance the blood pressure-lowering effect when taken with other antihypertensive drugs, so adjust the dosage under the guidance of a healthcare professional. Women who are pregnant or planning to become pregnant should not take this medication, and those who are breastfeeding should also avoid it. In case of overdose, symptoms like hypotension, dizziness, and rapid heartbeat may occur; consult a healthcare professional immediately if these symptoms develop. The safety and efficacy of this medication have not been established for children and adolescents; use is not recommended for those under 18 years of age. Care should be taken as dizziness or drowsiness may occur when driving or operating machinery. This medication should be stored out of reach of children and not transferred to other containers.

Side effects

  • dizziness
  • back pain
  • respiratory infections
  • upper respiratory infection
  • pharyngitis
  • rhinitis
  • fatigue
  • peripheral edema
  • chest pain
  • headache
Show 66 more
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • asthenia
  • fever
  • paresthesia
  • dyspepsia
  • gastroenteritis
  • tachycardia
  • palpitations
  • increase in creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hypokalemia
  • hyponatremia
  • hypoglycemia
  • intestinal vascular edema
  • increase in liver enzyme levels
  • hepatitis
  • elevation of AST
  • elevation of ALT
  • elevation of γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • renal impairment
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbances
  • diminished libido
  • forgetfulness
  • anorexia
  • increased appetite
  • tinnitus
  • taste disturbance
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to maintain a storage temperature between 1°C and 30°C to preserve the medication's efficacy and safety over time.

Appearance and packaging

Appearance

Pink, round, biconvex tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.